Quarterly Earnings At A Glance

On his last day as chairman of the Board of Governors of the Federal Reserve System, Alan Greenspan presides over his final Federal Open Market Committee meeting at the Fed's headquarters in Washington, Tuesday, Jan. 31, 2006. Greenspan has held the post for more than 18 years and is widely viewed as the most successful chairman in the Fed's 92-year history
AP Photo/J. Scott Applewhite
Biotechnology company Amgen finished ahead of analysts' expectations in the third quarter with earnings of 83 cents per share.

The company also said it will repurchase an additional $1 billion of its common stock.

Enter a ticker symbol


Symbol Lookup
Amgen (AMGN)
Amgen (AMGN) said third-quarter net income was $221 million, or 83 cents per share compared with $84 million, or 31 cents per share a year ago, including a charge. Without the charge, third-quarter earnings would have increased by 26 percent over the year-ago period, the company said.

Analysts surveyed by First Call anticipated the company's earnings to come in at 78 cents a share.

Net sales were up for the quarter: $700.9 million from $598.3 million, a year ago. Sales of Epogen, the company's kidney dialysis therapy, rose 23 percent to $350 million from $285 million a year ago.

Amgen also said it has completed its previously announced $1 billion stock repurchasing program, which began last October.